The identification of ESR1, NRP2, AXL, ERBB2, and GAB1 as key genes provides novel therapeutic targets and highlights the importance of understanding shared molecular pathways in osteoporosis and sarcopenia. The gene discussed is ESR1; the disease is sarcopenia.